Open Access

Complete genome sequence of Gordonia bronchialis type strain (3410T)

  • Natalia Ivanova
  • , Johannes Sikorski
  • , Marlen Jando
  • , Alla Lapidus
  • , Matt Nolan
  • , Susan Lucas
  • , Tijana Glavina Del Rio
  • , Hope Tice
  • , Alex Copeland
  • , Jan-Fang Cheng
  • , Feng Chen
  • , David Bruce,
  • , Lynne Goodwin,
  • , Sam Pitluck
  • , Konstantinos Mavromatis
  • , Galina Ovchinnikova
  • , Amrita Pati
  • , Amy Chen
  • , Krishna Palaniappan
  • , Miriam Land,
  • , Loren Hauser,
  • , Yun-Juan Chang,
  • , Cynthia D. Jeffries,
  • , Patrick Chain,
  • , Elizabeth Saunders,
  • , Cliff Han,
  • , John C. Detter,
  • , Thomas Brettin,
  • , Manfred Rohde
  • , Markus Göker
  • , Jim Bristow
  • , Jonathan A. Eisen,
  • , Victor Markowitz
  • , Philip Hugenholtz
  • , Hans-Peter Klenk
  • and Nikos C. Kyrpides
Corresponding author

DOI: 10.4056/sigs.611106

Received: 28 January 2010

Published: 28 February 2010


Gordonia bronchialis Tsukamura 1971 is the type species of the genus. G. bronchialis is a human-pathogenic organism that has been isolated from a large variety of human tissues. Here we describe the features of this organism, together with the complete genome sequence and annotation. This is the first completed genome sequence of the family Gordoniaceae. The 5,290,012 bp long genome with its 4,944 protein-coding and 55 RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project.


Obligate aerobichuman-pathogenicendocarditisGram-positivenon-motileGordoniaceae


Strain 3410T (= DSM 43247 = ATCC 25592 = JCM 3198) is the type strain of the species Gordonia bronchialis, which is the type species of the genus. The genus Gordonia (formerly Gordona) was originally proposed by Tsukamura in 1971 [1]. The generic name Gordona has been chosen to honor Ruth E. Gordon, who studied extensively ‘Mycobacteriumrhodochrous (included later as a member of Gordona) [1]. In 1977, it was subsumed into the genus Rhodococcus [2], but revived again in 1988 by Stackebrandt et al. [3]. At the time of writing, the genus contained 28 validly published species [4]. The genus Gordonia is of great interest for its bioremediation potential [5]. Some species of the genus have been used for the decontamination of polluted soils and water [6,7]. Other species were isolated from industrial waste water [8], activated sludge foam [9], automobile tire [10], mangrove rhizosphere [11], tar-contaminated oil [12], soil [13] and an oil-producing well [7]. Further industrial interest in Gordonia species stems from their use as a source of novel enzymes [14,15]. There are, however, quite a number of Gordonia species that are associated with human and animal diseases [16], among them G. bronchialis. Here we present a summary classification and a set of features for G. bronchalis 3410T, together with the description of the complete genomic sequencing and annotation.

Classification and features

Strain 3410T was isolated from the sputum of a patient with pulmonary disease (probably in Japan) [1]. Further clinical strains in Japan have been isolated from pleural fluid, tumor in the eyelid, granuloma, leukorrhea, skin tissue and pus [17]. In other cases, G. bronchialis caused bacteremia in a patient with a sequestrated lung [18] and a recurrent breast abscess in an immunocompetent patient [19]. Finally, G. bronchialis was isolated from sternal wound infections after coronary artery bypass surgery [20]. G. bronchialis shares 95.8-98.7% 16S rRNA gene sequence similarity with the other type strains of the genus Gordonia, and 95.3-96.4% with the type strains of the neighboring genus Williamsia.

Figure 1 shows the phylogenetic neighborhood of for G. bronchialis 3410T in a 16S rRNA based tree. The sequences of the two 16S rRNA gene copies in the genome of G. bronchialis 3410T, differ from each other by one nucleotide, and differ by up to 5 nucleotides from the previously published 16S rRNA sequence from DSM 43247 (X79287). These discrepancies are most likely due to sequencing errors in the latter sequence.

Figure 1

Phylogenetic tree highlighting the position of G. bronchialis 3410T relative to the other type strains within the genus Gordonia. The tree was inferred from 1,446 aligned characters [21,22] of the 16S rRNA gene sequence under the maximum likelihood criterion [23] and rooted with the type strains of the neighboring genus Williamsia. The branches are scaled in terms of the expected number of substitutions per site. Numbers above branches are support values from 1,000 bootstrap replicates if larger than 60%. Lineages with type strain genome sequencing projects registered in GOLD [24] are shown in blue, published genomes in bold.

In a very comprehensive study, Tsukamura analyzed a set of 100 quite diverse characters for 41 G. bronchialis strains isolated from sputum of patients with pulmonary disease, including the type strain [1]. Unfortunately, this study does not present the characteristics of the type strain 3410T as such. We nevertheless first present these data, as this study gives a good overview of the species itself. In order to summarize the data here, we regard positive reactions in more than 34 strains as positive, and positive reactions in only 13 or less strains as negative. Most characters, however, are either clearly positive (40 or 41 strains) or clearly negative (0 or 1 strains). The detailed methods are reported elsewhere [25,26].

G. bronchialis is Gram-positive (Table 1) and shows slight but not strong acid-fastness. A mycelium is not observed. G. bronchialis strains are non-motile and produce neither conidia nor endospores [1,3]. G. bronchialis is an obligately aerobic chemoorganotroph with an oxidative-type metabolism [3].The cells are rod-shaped and show compact grouping (like a cord) (Figure 2), and provide a rough colonial morphology with pinkish-brown colony pigmentation [1]. Photochromogenicity was not observed. G. bronchialis grows quite rapidly [1], with visible colonies appearing within 1-3 days [1,36]. G. bronchialis is positive for catalase and nitrate reduction, but arylsulphatase (3 days and 2 weeks), salicylate and PAS degradation was not observed [1]. Growth occurs on 0.2% sodium p-aminosalicylate and 62.5 and 125 µg NH2OH-HCl/ml, but not with 250 or 500 µg. G. bronchialis is tolerant to both 0.1 and 0.2% picric acid. G. bronchialis grows at 28°C and 37°C, but not at 45°C or 52°C [1]. G. bronchialis is positive for acetamidase, urease, nicotinamidase and pyrazinamidase, but negative for benzamidase, isonicotinamidase, salicylamidase, allanoinase, succinamidase, and malonamidase [1]. G. bronchialis utilizes acetate, succinate, malate, pyruvate, fumarate, glycerol, glucose, mannose, trehalose, inositul, fructose, sucrose, ethanol, propanol, and propylene glycol as a carbon source for growth, but not citrate, benzoate, malonate, galactose, arabinose, xylose, rhamnose, raffinose, mannitol, sorbitol, or various forms of butylene glycol (1,3-; 1,4-; 2,3-) [1]. G. bronchialis utilizes L-glutamate and acetamide as a N-C source, but not L-serine, benzamide, monoethanolamine or trimethylene diamine. Glucosamine is utilized by 18 strains [1]. G. bronchialis utilizes as nitrogen source L-glutamate, L-serine, L-methionine, acetamide, urea, pyrazinamide, isonicotinamide, nicotinamide, succinamide, but not benzamide and nitrite. Nitrate is utilized by 25 strains as nitrogen source [1]. G. bronchialis strains do not produce nicotinic acid. G. bronchialis strains do not grow on TCH medium (10 µg/ml) or on salicylate medium (0.05% and 0.01%) [1].

Table 1

Classification and general features of G. bronchialis 3410T according to the MIGS recommendations [27]




Evidence code

Current classification

Domain Bacteria

TAS [28]

Phylum Actinobacteria

TAS [29]

Class Actinobacteria

TAS [30]

Order Actinomycetales

TAS [30]

Suborder Corynebacterineae

TAS [30,31]

Family Gordoniaceae

TAS [30]

Genus Gordonia

TAS [3,30,32]

Species Gordonia bronchialis

TAS [1]

Type strain 3410

TAS [1]

Gram stain


TAS [1]

Cell shape

short rods in compact grouping (cord-like)

TAS [1]



TAS [1]



TAS [1]

Temperature range

grows at 28°C and 37°C, not at 45°C

TAS [1]

Optimum temperature

probably between 28°C and 37°C

TAS [1]



TAS [33]


Oxygen requirement

obligate aerobe

TAS [1]

Carbon source

mono- and disaccharides

TAS [1]

Energy source


TAS [3]




TAS [1]


Biotic relationship

free living




opportunistic pathogen

TAS [1,17-20]

Biosafety level


TAS [34]


sputum from human with pulmonarydisease in (probably) Japan

TAS [1]


Geographic location


TAS [1,17-20]


Sample collection time

1971 or before

TAS [1]

MIGS-4.1 MIGS-4.2

Latitude, Longitude

not reported



not reported



not reported

Evidence codes - IDA: Inferred from Direct Assay (first time in publication); TAS: Traceable Author Statement (i.e., a direct report exists in the literature); NAS: Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from of the Gene Ontology project [35]. If the evidence code is IDA, then the property was directly observed for a live isolate by one of the authors or an expert mentioned in the acknowledgements.

Figure 2

Scanning electron micrograph of G. 
bronchialis 3410T

In the following, characteristics of the type strain 3410T are presented: strain 3410T reduces nitrate and hydrolyses urea, but it does not hydrolyze aesculin, allantoin or arbutin [37]. It decomposes (%, w/v) starch (1) and uric acid (0.5), but not hypoxanthine (0.4), tributyrin (0.1), tween 80 (1), tyrosine (0.5) and xanthine (0.4) [37]. It grows on glycerol (1) and sodium fumarate (1) as sole carbon sources (%, w/v), but not on arbutin (1), D-cellobiose (1), N-acetyl-D-glucosamine (0.1), adipic acid (0.1), betaine (0.1), oxalic acid (0.1), propan-1-ol (0.1) [37]. Strain 3410T grows in the presence (% w/v) of oleic acid (0.1) and zinc chloride (0.001) [37].

In an API ZYM test, strain 3410T reacts positively for alkaline phosphatase, butyrate esterase, leucine arylamidase and naphtol-AS-BI-phosphohydrolase, but not for caprylate esterase, cystine arylamidase, β-glucosidase, myristate lipase, and valine arylamidase [13]. Complementary to the results of Tsukamura [1], strain 3410T utilizes as sole carbon source D(+) cellobiose, D(+) galactose, D(+) mannose, meso-inositol, L(+) rhamnose and sodium succinate, but not D(-)lactose, D(-) ribose, sodium benzoate and sodium citrate [38]. The use of D(+) galactose [38] might contrast above reported results from Tsukamura [1]. L-threonine and L-valinine are used as sole nitrogen source by strain 3410T, but not L-asparagine, L-proline and L-serine [38]. Interestingly, Tsukamura reports that 40 out of 41 strains utilize L-serine as sole nitrogen source [1], and it is not clear if the only negative strain in the Tsukamura study could be the type strain 3410T [1].

In the BiOLOG system, strain 3410T reacts positively for α-cyclodextrin, β-cyclodextrin, dextrin, glycogen, maltose, maltotriose, D -mannose, 3-methyl glucose, palatinose, L-raffinose, salicin, turanose, D-xylose, L-lactic acid, methyl succinate, N-acetyl- L-glutamic acid [12], but not for N-acetylglucosamine, amygdalin, D-arabitol, L-Rhamnose, D-ribose, D-sorbitol, D-trehalose, acetic acid, α-hydroxybutyric acid, β-hydroxybutyric acid, α-ketoglutaric acid, α-ketovaleric acid, L-lactic acid methyester, L-malic acid, propionic acid, succinamic acid, alaninamide, L-alanine and glycerol [12]. Further carbon source utilization results are published elsewhere [8].

Drug susceptibility profiles of 13 G. bronchialis strains from clinical samples have been examined in detail [17], but they are too complex to summarize here. No significant matches with any 16S rRNA sequences from environmental genomic samples and surveys are reported at the NCBI BLAST server (November 2009).


The cell-wall peptidoglycan is based upon meso-diaminopimelic acid (variation Alγ). The glycan moiety of the peptidoglycan contains N-glycolylmuramic acid. The wall sugars are arabinose and galactose. Mycolic acids are present with a range of ca. 48-66 carbon atoms. The predominant menaquinone is MK-9(H2), with only low amounts of MK-9(H0), MK-8(H2), and MK-7(H2) [3,8,39-41]. Moreover, the cell envelope of G. bronchialis 3410T contains a lipoarabinomannan-like lipoglycan [42]. The same study also observed a second amphiphilic fraction with properties suggesting a phosphatidylinositol mannoside [42]. The cellular fatty acid composition (%) is C16:0 (23), tuberculostearic acid (20), C16:1cis9 (16), C16:1cis7 (11), C18:1 (10), and 10-methyl C17:0 (7). All other fatty acids are at 3% or below [8].

Genome sequencing and annotation

Genome project history

This organism was selected for sequencing on the basis of its phylogenetic position, and is part of the Genomic Encyclopedia of Bacteria and Archaea project. The genome project is deposited in the Genome OnLine Database [24] and the complete genome sequence is deposited in GenBank. Sequencing, finishing and annotation were performed by the DOE Joint Genome Institute (JGI). A summary of the project information is shown in Table 2.

Table 2

Genome sequencing project information





  Finishing quality



  Libraries used

     Two Sanger libraries: 8kb pMCL200 and fosmid pcc1Fos     One 454 Pyrosequence standard library


  Sequencing platforms

     ABI3730, 454 GS FLX


  Sequencing coverage

     7.98× Sanger; 23.2× Pyrosequence



     Newbler, phrap


  Gene calling method

     Prodigal, GenePRIMP



  GenBank Date of Release

     October 28, 2009



  NCBI project ID


  Database: IMG-GEBA



  Source material identifier

     DSM 43247

  Project relevance

     Tree of Life, GEBA

Growth conditions and DNA isolation

G. bronchialis 3410T, DSM 43247, was grown in DSMZ 535 [43] at 28°C. DNA was isolated from 1-1.5 g of cell paste using Qiagen Genomic 500 DNA Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions with modification st/LALMP for cell lysis according to Wu et al. [44].

Genome sequencing and assembly

The genome was sequenced using a combination of Sanger and 454 sequencing platforms. All general aspects of library construction and sequencing performed at the JGI can be found on the JGI website. 454 Pyrosequencing reads were assembled using the Newbler assembler version (Roche). Large Newbler contigs were broken into 5,776 overlapping fragments of 1,000 bp and entered into assembly as pseudo-reads. The sequences were assigned quality scores based on Newbler consensus q-scores with modifications to account for overlap redundancy and to adjust inflated q-scores. A hybrid 454/Sanger assembly was made using the parallel phrap assembler (High Performance Software, LLC). Possible mis-assemblies were corrected with Dupfinisher [45] or transposon bombing of bridging clones (Epicentre Biotechnologies, Madison, WI). Gaps between contigs were closed by editing in Consed, custom primer walk or PCR amplification. A total of 876 primer walk reactions, 12 transposon bombs, and 1 pcr shatter libraries were necessary to close gaps, to resolve repetitive regions, and to raise the quality of the finished sequence. The error rate of the completed genome sequence is less than 1 in 100,000. Together all sequence types provided 51.2 × coverage of the genome. The final assembly contains 52,329 Sanger and 508,130 pyrosequence reads.

Genome annotation

Genes were identified using Prodigal [46] as part of the Oak Ridge National Laboratory genome annotation pipeline, followed by a round of manual curation using the JGI GenePRIMP pipeline [47]. The predicted CDSs were translated and used to search the National Center for Biotechnology Information (NCBI) nonredundant database, UniProt, TIGRFam, Pfam, PRIAM, KEGG, COG, and InterPro databases. Additional gene prediction analysis and manual functional annotation was performed within the Integrated Microbial Genomes Expert Review (IMG-ER) platform [48].

Genome properties

The genome consists of a 5.2 Mbp long chromosome and a 81,410 bp plasmid (Table 3 and Figure 3). Of the 4,999 genes predicted, 4,944 were protein coding genes, and 55 RNAs; 264 pseudogenes were also identified. The majority of the protein-coding genes (69.1%) were assigned with a putative function while those remaining were annotated as hypothetical proteins. The distribution of genes into COGs functional categories is presented in Table 4.

Table 3

Genome Statistics



% of Total

Genome size (bp)



DNA coding region (bp)



DNA G+C content (bp)



Number of replicons


Extrachromosomal elements


Total genes



RNA genes



rRNA operons


Protein-coding genes



Pseudo genes



Genes with function prediction



Genes in paralog clusters



Genes assigned to COGs



Genes assigned Pfam domains



Genes with signal peptides



Genes with transmembrane helices



CRISPR repeats


Figure 3

Graphical circular map of the chromosome and the plasmid. From outside to the center: Genes on forward strand (color by COG categories), Genes on reverse strand (color by COG categories), RNA genes (tRNAs green, rRNAs red, other RNAs black), GC content, GC skew.

Table 4

Number of genes associated with the general COG functional categories








    Translation, ribosomal structure and biogenesis




    RNA processing and modification








    Replication, recombination and repair




    Chromatin structure and dynamics




    Cell cycle control, mitosis and meiosis




    Nuclear structure




    Defense mechanisms




    Signal transduction mechanisms




    Cell wall/membrane biogenesis




    Cell motility








    Extracellular structures




    Intracellular trafficking and secretion




    Posttranslational modification, protein turnover, chaperones




    Energy production and conversion




    Carbohydrate transport and metabolism




    Amino acid transport and metabolism




    Nucleotide transport and metabolism




    Coenzyme transport and metabolism




    Lipid transport and metabolism




    Inorganic ion transport and metabolism




    Secondary metabolites biosynthesis, transport and catabolism




    General function prediction only




    Function unknown




    Not in COGs



We would like to gratefully acknowledge the help of Susanne Schneider (DSMZ) for DNA extraction and quality analysis. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396, as well as German Research Foundation (DFG) INST 599/1-1.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


  1. Tsukamura M. Proposal of a new genus, Gordona, for slightly acid-fast organisms occurring in sputa of patients with pulmonary disease and in soil. J Gen Microbiol. 1971; 68:15-26PubMed
  2. Goodfellow M and Alderson G. The Actinomycete-genus Rhodococcus: A Home for the 'rhodochrous' Complex. J Gen Microbiol. 1977; 100:99-122PubMed
  3. Stackebrandt E, Smida J and Collins MD. Evidence of phylogenetic heterogeneity within the genus Rhodococcus: revival of the genus Gordona (Tsukamura). J Gen Appl Microbiol. 1988; 34:341-348 View Article
  4. Euzéby JP. List of bacterial names with standing in nomenclature: A folder available on the Internet. Int J Syst Bacteriol. 1997; 47:590-592PubMed
  5. Yoon JH, Lee J, Kang S, Takeuchi M, Shin Y, Lee S, Kang K and Park Y. Gordonia nitida sp. nov., a bacterium that degrades 3-ethylpyridine and 3-methylpyridine. Int J Syst Evol Microbiol. 2000; 50:1203-1210PubMed
  6. Bell KS, Philp JC, Aw DWJ and Christofi N. The genus Rhodococcus. J Appl Microbiol. 1998; 85:195-210 View ArticlePubMed
  7. Xue Y, Sun X, Zhou P, Liu R, Liang F and Ma Y. Gordonia paraffinivorans sp. nov., a hydrocarbon-degrading actinomycete isolated from an oil-producing well. Int J Syst Evol Microbiol. 2003; 53:1643-1646 View ArticlePubMed
  8. Kim KK, Lee CS, Kroppenstedt RM, Stackebrandt E and Lee ST. Gordonia sihwensis sp. nov., a novel nitrate-reducing bacterium isolated from a wastewater-treatment bioreactor. Int J Syst Evol Microbiol. 2003; 53:1427-1433 View ArticlePubMed
  9. Soddell JA, Stainsby FM, Eales KL, Seviour RJ and Goodfellow M. Gordonia defluvii sp. nov., an actinomycete isolated from activated sludge foam. Int J Syst Evol Microbiol. 2006; 56:2265-2269 View ArticlePubMed
  10. Linos A, Steinbüchel A, Spröer C and Kroppenstedt RM. Gordonia polyisoprenivorans sp. nov., a rubber-degrading actinomycete isolated from an automobile tyre. Int J Syst Bacteriol. 1999; 49:1785-1791PubMed
  11. Takeuchi M and Hatano K. Gordonia rhizosphera sp. nov. isolated from the mangrove rhizosphere. Int J Syst Bacteriol. 1998; 48:907-912PubMed
  12. Kummer C, Schumann P and Stackebrandt E. Gordonia alkanivorans sp. nov., isolated from tar-contaminated soil. Int J Syst Bacteriol. 1999; 49:1513-1522PubMed
  13. Shen FT, Goodfellow M, Jones AL, Chen YP, Arun AB, Lai WA, Rekha PD and Young CC. Gordonia soli sp. nov., a novel actinomycete isolated from soil. Int J Syst Evol Microbiol. 2006; 56:2597-2601 View ArticlePubMed
  14. Kim SB, Brown R, Oldfield C, Gilbert S, Iliarionov S and Goodfellow M. Gordonia amicalis sp. nov., a novel dibenzothiophene-desulphurizing actinomycete. Int J Syst Evol Microbiol. 2000; 50:2031-2036PubMed
  15. Kim SB, Brown R, Oldfield C, Gilbert SC and Goodfellow M. Gordonia desulfuricans sp. nov., a benzothiophene-desulphurizing actinomycete. Int J Syst Bacteriol. 1999; 49:1845-1851PubMed
  16. Goodfellow M, Maldonado LA. 2006. The families Dietziaceae, Gordoniaceae, Nocardiaceae and Tsukamurellaceae In: F Dworkin, S Falkow, KH Schleifer E Stackebrandt (eds), The Prokaryotes, Archaea, Bacteria, Firmacutes, Actinomycetes, vol. 3. Springer, New York.
  17. Aoyama K, Kang Y, Yazawa K, Gonoi T, Kamei K and Mikami Y. Characterization of clinical isolates of Gordonia species in japanese clinical samples during 1998-2008. Mycopathologia. 2009; 168:175-183 View ArticlePubMed
  18. Sng LH, Koh TH, Toney SR, Floyd M, Butler WR and Tan BH. Bacteremia caused by Gordonia bronchialis in a patient with sequestrated lung. J Clin Microbiol. 2004; 42:2870-2871 View ArticlePubMed
  19. Werno AM, Anderson TP, Chambers ST, Laird HM and Murdoch DR. Recurrent breast abscess caused by Gordonia bronchialis in an immunocompetent patient. J Clin Microbiol. 2005; 43:3009-3010 View ArticlePubMed
  20. Richet HM, Craven PC, Brown JM, Lasker BA, Cox CD, McNeil MM, Tice AD, Jarvis WR and Tablan OC. A cluster of Rhodococcus (Gordona) bronchialis sternal-wound infections after coronary-artery bypass surgery. N Engl J Med. 1991; 324:104-109PubMed
  21. Castresana J. Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol. 2000; 17:540-552PubMed
  22. Lee C, Grasso C and Sharlow MF. Multiple sequence alignment using partial order graphs. Bioinformatics. 2002; 18:452-464 View ArticlePubMed
  23. Stamatakis A, Hoover P and Rougemont J. A Rapid Bootstrap Algorithm for the RAxML Web Servers. Syst Biol. 2008; 57:758-771 View ArticlePubMed
  24. Liolios K, Mavromatis K, Tavernarakis N and Kyrpides NC. The Genomes On Line Database (GOLD) in 2007: status of genomic and metagenomic projects and their associated metadata. Nucleic Acids Res. 2008; 36:D475-D479 View ArticlePubMed
  25. Tsukamura M. Identification of mycobacteria. Tubercle, London. 1967; 48:311-338 View Article
  26. Tsukamura M. Adansonian classification of mycobacteria. J Gen Microbiol. 1966; 45:253-273PubMed
  27. Field D, Garrity G, Gray T, Morrison N, Selengut J, Sterk P, Tatusova T, Thomson N, Allen MJ and Angiuoli SV. The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol. 2008; 26:541-547 View ArticlePubMed
  28. Woese CR, Kandler O and Wheelis ML. Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proc Natl Acad Sci USA. 1990; 87:4576-4579 View ArticlePubMed
  29. Garrity GM, Holt JG. The Road Map to the Manual. In: Garrity GM, Boone DR, Castenholz RW (eds), Bergey's Manual of Systematic Bacteriology, Second Edition, Volume 1, Springer, New York, 2001, p. 119-169.
  30. Stackebrandt E, Rainey FA and Ward-Rainey NL. Proposal for a new hierarchic classification system, Actinobacteria classis nov. Int J Syst Bacteriol. 1997; 47:479-491
  31. Zhi XY, Li WJ and Stackebrandt E. An update of the structure and 16S rRNA gene sequence-based definition of higher ranks of the class Actinobacteria, with the proposal of two new suborders and four new families and emended descriptions of the existing higher taxa. Int J Syst Evol Microbiol. 2009; 59:589-608 View ArticlePubMed
  32. Editor L. Validation List No. 30. Validation of the publication of new names and new combinations previously effectively published outside the IJSB. Int J Syst Bacteriol. 1989; 39:371
  33. Wink JM. Compendium of Actinobacteria 2009.Web Site
  34. Agents B. Technical rules for biological agents TRBA 466.Web Site
  35. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS and Eppig JT. Gene Ontology: tool for the unification of biology. Nat Genet. 2000; 25:25-29 View ArticlePubMed
  36. Chun J, Blackall LL, Kang S-O, Hah YC and Goodfellow M. A proposal to reclassify Nocardia pinensis Blackall et al. as Skermania piniformis gen. nov., comb. nov. Int J Syst Bacteriol. 1997; 47:127-131PubMed
  37. Brandão PFB, Maldonado LA, Ward AC, Bull AT and Goodfellow M. Gordonia namibiensis sp. nov., a novel nitrile metabolising actinomycete recovered from an African sand. Syst Appl Microbiol. 2001; 24:510-515 View ArticlePubMed
  38. le Roes M, Goodwin CM and Meyers PR. Gordonia lacunae sp. nov., isolated from an estuary. Syst Appl Microbiol. 2008; 31:17-23 View ArticlePubMed
  39. Alshamaony L, Goodfellow M, Minnikin DE and Mordarska H. Free mycolic acids as criteria in the classification of Gordona and the 'rhodochrous' complex. J Gen Microbiol. 1976; 92:183-187PubMed
  40. Collins MD, Pirouz T, Goodfellow M and Minnikin DE. Distribution of menaquinones in actinomycetes and corynebacteria. J Gen Microbiol. 1977; 100:221-230PubMed
  41. Collins MD, Goodfellow M, Minnikin DE and Alderson G. Menaquinone composition of mycolic acid-containing actinomycetes and some sporoactinomycetes. J Appl Bacteriol. 1985; 58:77-86PubMed
  42. Garton NJ and Sutcliffe IC. Identification of a lipoarabinomannan-like lipoglycan in the actinomycete Gordonia bronchialis. Arch Microbiol. 2006; 184:425-427 View ArticlePubMed
  43. List of growth media used at DSMZ: Web Site
  44. Wu D, Hugenholtz P, Mavromatis K, Pukall R, Dalin E, Ivanova N, Kunin V, Goodwin L, Wu M and Tindall BJ. A phylogeny-driven genomic encyclopedia of Bacteria and Archaea. Nature. 2009; 462:1056-1060 View ArticlePubMed
  45. Sims D, Brettin T, Detter J, Han C, Lapidus A, Copeland A, Glavina Del Rio T, Nolan M, Chen F and Lucas S. Complete genome sequence of Kytococcus sedentarius type strain (541T). Stand Genomic Sci. 2009; 1:12-20 View Article
  46. Anonymous. Prodigal Prokaryotic Dynamic Programming Genefinding Algorithm. Oak Ridge National Laboratory and University of Tennessee 2009 Web Site
  47. Pati A, Ivanova N, Mikhailova N, Ovchinikova G, Hooper SD, Lykidis A and Kyrpides NC. GenePRIMP: A Gene Prediction Improvement Pipeline for microbial genomes. (Submitted).
  48. Markowitz VM, Ivanova NN, Chen IMA, Chu K and Kyrpides NC. IMG ER: a system for microbial genome annotation expert review and curation. Bioinformatics. 2009; 25:2271-2278 View ArticlePubMed
  49. Park S, Kang SJ, Kim W and Yoon JH. Gordonia hankookensis sp. nov., isolated from soil. Int J Syst Evol Microbiol. 2009; 59:3172-3175 View ArticlePubMed